Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou're a few weeks into Wegovy and your appetite has shifted noticeably — portions that felt normal before now feel like too much. That change is real, and it creates an opportunity: the reduced hunger semaglutide produces is most useful when the food you do eat is working hard for you. A thoughtful Wegovy nutrition plan isn't about rigid rules; it's about making the calories you consume count, protecting muscle, and keeping side effects manageable. Wegovy (semaglutide) is a prescription-only medicine licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with a weight-related condition — a prescriber decides whether it's clinically appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture your first or second pen arriving, plain box, DPD tracking notification on your phone, the pre-filled pen itself smaller than you might have expected. You inject, and within a day or two the world of food feels different. Nausea is the most commonly reported side effect in the early weeks, and what you eat has a direct effect on how bad it gets.
Small, frequent meals tend to sit better than two or three large ones. Bland, lower-fat options (plain rice, boiled eggs, oats, steamed vegetables, toast) give your stomach less to process at a time when gastric emptying has already slowed. Greasy food, very spicy dishes and rich sauces are the usual culprits when nausea tips into vomiting early in treatment. That's not a permanent restriction; for most people the GI picture settles within a few weeks as the body adjusts.
Eat slowly and stop before you feel completely full. Semaglutide amplifies the satiety signal, so the old pacing cues don't apply in the same way. Eating past the point of comfort on a slowed stomach is one of the more reliable ways to guarantee reflux or vomiting. Smaller plates can help recalibrate expectations without any sense of deprivation. The practical Wegovy menu plan page covers day-by-day meal ideas if you want a worked example.
Reduced appetite is the mechanism, but it carries a risk most people don't anticipate. When overall calorie intake drops sharply and protein doesn't keep pace, the body draws on muscle mass to meet its energy needs alongside fat. That erodes the metabolic rate you're trying to protect, and it makes weight maintenance harder once treatment eventually ends.
A practical target for most adults on a weight-loss medicine is roughly 1.2–1.6 g of protein per kilogram of body weight per day, though your prescriber or a registered dietitian can give you a figure that fits your specific situation. In meal terms: eggs at breakfast, a protein source at lunch (chicken, fish, legumes, cottage cheese, tofu), and a substantial protein portion at dinner. Greek yoghurt and edamame are useful snacks that don't sit heavily.
If appetite is very suppressed and hitting protein targets feels difficult, liquid sources help, a small protein shake, a mug of lentil soup, or skyr. The goal isn't a high-protein diet in the performance sense; it's simply maintaining an adequate baseline when total food volume has fallen. The NHS guidance on healthy weight and nutrition provides a useful foundation here.
Muscle retention also responds to resistance exercise. Wegovy's licence involves weight management alongside lifestyle changes, and strength-based activity (even bodyweight work) is part of protecting that baseline. This is worth raising with your prescriber or a physiotherapist if you're not sure where to start.
Semaglutide slows gastric emptying, that's part of how it reduces hunger. A useful side effect for appetite; a less welcome one for bowel regularity. Constipation affects a meaningful proportion of people on the treatment, and it's one of the reasons that what you eat matters beyond just calories and protein.
Soluble fibre from oats, lentils, beans, apples and root vegetables adds bulk and helps maintain movement through a slowed gut. Insoluble fibre from wholegrains, leafy greens and brassicas adds further structure. The simplest daily target is plenty of both, which in practice means fruit or vegetables at most meals and wholegrains where possible. If appetite is very low, even a handful of frozen vegetables stirred into something is better than a meal that's pure protein and nothing else.
Fluids are just as important and easier to overlook. A blunted appetite can also reduce thirst perception. Aiming for around 1.5–2 litres of water or low-calorie fluids per day supports kidney function, helps with constipation, and reduces the headache and fatigue some people notice in the early weeks. If severe vomiting or diarrhoea ever makes keeping fluids down difficult, that's a situation requiring medical attention, dehydration can progress quickly and is worth taking seriously. The page on nutritional risk during Wegovy treatment covers what to watch for in more detail.
For people thinking through how this fits into a longer-term approach, the broader Wegovy weight loss plan page looks at the lifestyle framework around the medicine, not just the eating component.
Most people on Wegovy are eventually working towards a dose they'll stay on for months, 2.4 mg weekly under the standard schedule, or up to 7.2 mg following the MHRA's approval of the higher-dose pen in April 2026. At maintenance, the acute nausea of the early weeks has usually passed, appetite is stable at a lower level, and the nutrition focus shifts.
The priority at this stage is eating in a way you can sustain. Highly restrictive eating patterns that depend entirely on the medicine suppressing hunger tend to collapse when the treatment ends or is interrupted. Building actual eating habits (regular meals, variety, adequate protein and fibre, minimal ultra-processed food) gives you a structure that works independently of the drug's effect.
Mediterranean-style eating has the strongest evidence base for long-term weight maintenance and cardiovascular health: olive oil, fish, legumes, vegetables, wholegrains, moderate dairy. It also happens to sit well with the GI profile of semaglutide, mostly lower in saturated fat, high in fibre, not heavily processed. It's not the only approach, but it's a useful reference point if you're not sure where to start.
You can explore the full semaglutide treatment overview for context on how the medicine works within a wider weight management plan. If you're still at the stage of deciding whether Wegovy is the right route for you, the weight loss treatment overview lays out the options clearly. The cost of private treatment is something many people ask about early on; a straightforward breakdown is available on the Wegovy private prescription page.
When you're ready to talk through your specific situation, our prescribers are here. Speak to our prescribers through a free consultation, no referral required, reviewed the same day by a GPhC-registered clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.